Core Insights - The brain-computer interface (BCI) industry in China is experiencing significant advancements, with clinical results emerging for high-level paraplegics controlling devices through thought, and strong financing support from unicorn companies like Strong Brain Technology, which raised approximately 2 billion yuan, marking the second-largest funding record globally in this field [1][2] - The industry is positioned for rapid commercialization, driven by technological breakthroughs, capital influx, and supportive policies, as it transitions from cutting-edge technology to practical applications in daily life [1][2] Technological Breakthroughs - Recent advancements in the BCI field include successful clinical trials for invasive BCIs, with patients able to control smart wheelchairs and robotic dogs, showcasing the technology's potential for enhancing autonomy in daily life [2] - The development of high-throughput wireless invasive BCI systems has been achieved, with significant reductions in signal transmission delays to under 100 milliseconds, facilitating practical applications beyond laboratory settings [2] Market Demand and Application - The initial target demographic for BCI technology includes patients with conditions such as stroke, epilepsy, Parkinson's disease, and paralysis, who show strong willingness to try and pay for early products, indicating a broad medical market potential [3] - Current clinical applications focus on restoring motor and speech functions, with significant progress in motor rehabilitation for patients with spinal cord injuries and strokes, as well as breakthroughs in speech function restoration for patients with severe speech disorders [3] Policy and Capital Support - The BCI industry benefits from comprehensive policy support, including its designation as one of the six future industries in the 14th Five-Year Plan, and specific initiatives from various government departments to promote innovation and development in the sector [4][5] - Recent policy changes in regions like Sichuan have established clear pricing for BCI medical services, enhancing the financial viability of these technologies and facilitating their clinical application [4] Industry Standardization and Future Outlook - The BCI industry is expected to move towards standardization and scalability, with preliminary industry standards anticipated to be established by 2027-2028, paving the way for broader application and brand emergence by 2030 [6][7] - The domestic BCI industry possesses significant advantages, including strong policy support, a vast clinical resource base, and a complete supply chain, which collectively foster the industry's growth [7] Investment Opportunities - The BCI sector presents dual investment attributes in both medical and technological domains, with short-term focus on disease treatment and long-term potential for enhancing human capabilities through integration with AI and robotics, potentially unlocking a trillion-yuan market [7]

Core Insights - The news highlights the rapid development and investment in AI technologies, particularly in AI glasses, AI phones, and brain-computer interfaces, driven by policy support, technological breakthroughs, and market demand [1][2][4][6] AI Glasses - The 2026 International Consumer Electronics Show (CES) focuses on AI glasses, emphasizing lightweight design, strong interactivity, and full-scene applications as key trends [2] - Major companies are set to launch several AI glasses products in 2026, including Google's Project Aura and Apple's AI glasses, with IDC predicting a shipment volume of 4.508 million smart glasses in China, a 77.7% year-on-year increase [2] - The industry is witnessing increased orders, with companies like Visionary Technology and Huanxu Electronics ramping up production to meet rising demand for AI glasses [3] AI Phones - AI phones are expected to activate a new wave of device upgrades, with multiple Android manufacturers planning to release AI phones in early 2026 [4] - The evolution of AI phones is marked by a shift from mere computational upgrades to a fundamental restructuring of underlying systems, akin to past revolutions in computing and mobile operating systems [4] - The demand for AI phones is driving growth in the upstream supply chain, with companies like Bowei Alloy anticipating significant orders for components needed in high-end AI phone models [4] Brain-Computer Interfaces - The brain-computer interface sector is gaining momentum, with companies like Neuralink planning large-scale production starting in 2026 and Qiangnao Technology recently securing approximately 2 billion yuan in funding [6] - Government policies are increasingly supporting the development of brain-computer interfaces, with initiatives in cities like Beijing and Shanghai aimed at fostering innovation and establishing key enterprises in the sector [6] - Domestic companies are making significant technological advancements, such as Hanwei Technology's breakthroughs in non-invasive flexible brain-computer interface materials and collaborations with medical institutions [6]

Group 1: Market Trends and Developments - The brain-computer interface (BCI) sector is transitioning from clinical validation to commercial scalability, with 2026 expected to be a pivotal year for industrialization [2] - China's BCI market is projected to grow from 3.2 billion yuan in 2024 to 5.58 billion yuan in 2027, reflecting a compound annual growth rate of approximately 20% [2] - Global BCI market is anticipated to exceed 40 billion USD by 2030 [2] Group 2: Company Innovations and Collaborations - Yingkang Life has developed a comprehensive management solution for Parkinson's treatment using BCI technology, having completed over 20 deep brain stimulation surgeries [2] - Cheng Yi Tong's recent patent for "brainwave acquisition devices" is expected to enhance its core technology and market share in the BCI field [3] - Entropy Technology plans to launch a prototype BCI product by March 2026, focusing on commercial applications [3] - Yingqu Technology collaborates with various partners to develop BCI-related products, including brainwave monitoring headbands and rehabilitation robots [4] - Hanwei Technology has made breakthroughs in non-invasive flexible BCI materials, although commercial applications remain uncertain [5] - Daoshi Technology has strategically invested in Qiangnao Technology to enhance its capabilities in BCI applications across medical rehabilitation and education [6] - Sanbo Brain Science is advancing its "North Brain No. 2" project, focusing on flexible microelectrode technology for clinical applications [7] - Meihua Medical is a strategic partner in the cochlear implant sector, which is a significant application of BCI technology [7] Group 3: Investment and Strategic Partnerships - Leidi Ke has acquired a 20.41% stake in Aoyi Technology, which specializes in both BCI and robotics, enhancing its capabilities in the medical and health sectors [9] - Lihua Science and Technology's subsidiary, Weiling Medical, is developing a fully implanted wireless BCI system [10] - Guiyan Biotech is exploring precious metal materials for BCI applications, with some products in the experimental stage [11]

Group 1: Industry Overview - Brain-computer interface (BCI) technology is at a critical juncture of "technological breakthrough to commercialization," supported by policies, technology, and application scenarios [2] - The global market for BCI is expected to change due to policy benefits, external production expectations, and domestic clinical breakthroughs [2] - Invasive BCI products are still in clinical trials, while non-invasive products, such as rehabilitation systems and sleep aids, have been partially launched [2] Group 2: Technological Advancements - Advancements in chips, electrodes, and algorithms, along with improved regulatory standards, are expected to lead to intensive commercialization of BCI products in the coming years [2] - Companies like Neuralink plan to start large-scale production of BCI devices by 2026, with significant innovations in surgical procedures [2] Group 3: Competitive Landscape - The BCI industry in China is still in its early stages, with most companies being small in scale [2] - There is a notable advantage in the signal quality of invasive BCIs, while non-invasive BCIs offer high safety and ease of operation, serving as a complement to invasive types [2] Group 4: Industry Chain and Key Players - Upstream: Innovative Medical has strategically invested in Hangzhou Boling Medical Technology to enter the BCI field [3] - Midstream: Nanjing Panda is developing key technologies for multimodal human-computer interaction systems based on BCI technology [6] - Downstream: Sanbo Neuroscience has achieved breakthroughs in precise tumor removal technology and is exploring clinical applications related to brain science [8]

Investment Rating - The report maintains a positive investment rating for the brain-computer interface (BCI) industry, highlighting significant investment opportunities expected in 2026 [2]. Core Insights - The brain-computer interface industry is entering a golden period of development, with a broad blue ocean market. Global strategic layouts are being actively pursued by the US, EU, Japan, and other regions, leading to a growing number of companies and active investment activities [1]. - The BCI technology is at a critical stage of transitioning from technological breakthroughs to practical applications, with the market expected to grow significantly over the next decade. The global BCI market is projected to reach approximately $2.94 billion by 2025 and grow to about $12.4 billion by 2034, with a compound annual growth rate (CAGR) of 17.35% from 2025 to 2034 [6][20]. - The report emphasizes the importance of policy support and technological advancements in driving the growth of the BCI industry, with significant investments and initiatives from various governments [20][30]. Industry Overview - The BCI technology has evolved through three stages: the initial stage (1.0), the development stage (2.0), and the current intelligent and integrated stage (3.0) [20]. - The BCI market is characterized by diverse applications, with at least 30 identified use cases across medical, consumer, and industrial sectors. Medical applications currently dominate, accounting for 56% of the industry, while non-medical applications are rapidly expanding [18][19]. Market Size and Growth - The BCI market is expected to experience accelerated growth in the next decade, driven by the increasing adoption of BCI technologies across various sectors. The report forecasts a significant rise in market size, with a focus on the rapid development of non-invasive BCI technologies [6][20]. - The report highlights that the US and China are leading the global BCI technology and industry development, with major companies like Neuralink and Qiang Brain Technology making significant advancements [6][20]. Investment Recommendations - The report recommends focusing on companies involved in BCI technology, particularly those with strong market positions such as Dao Technology (which has a stake in Qiang Brain Technology) and other related firms in the flexible sensor sector [6][20]. - It also suggests monitoring developments in the medical device sector related to BCI technologies, emphasizing the importance of medical-grade BCI products [6][20].

Core Viewpoint - The article highlights the performance of the China Securities 2000 ETF managed by Harvest Fund Management, noting significant gains in both the ETF and its underlying stocks since its inception. Group 1: ETF Performance - The China Securities 2000 ETF (159535) increased by 1.91% to 1.547 yuan, with a trading volume of 6.4175 million yuan [1] - Since its establishment on September 14, 2023, the ETF has achieved a return of 51.12%, with a monthly return of 7.40% [1] Group 2: Top Holdings Performance - Among the top holdings, Huasheng Tiancheng rose by 5.04%, Hanwei Technology by 3.73%, and Haili Co. by 1.00% [1] - Conversely, Shijia Photon fell by 5.69%, while Dongtu Technology surged by 8.88%, and Meirihudong increased by 15.89% [1] - Other notable movements include Hongchuang Holdings down by 0.07%, Juguang Technology down by 2.20%, Yongding Co. up by 0.20%, and Meihu Co. down by 0.74% [1]

机械设备 机械设备 2026 年 01 月 11 日 投资评级：看好（维持） ——行业周报 行业走势图 数据来源：聚源 -14% 0% 14% 29% 43% 58% 72% 2025-01 2025-05 2025-09 机械设备 沪深300 相关研究报告 《马斯克宏图的下一个篇章：脑机接 口，2026 年将启动大规模量产，有望 解锁人机协同终极形态—行业周报》 -2026.1.4 《技术进化的 2025，走向量产的 2026， 人形机器人"黄金十年"启幕—行业 点评报告》-2025.12.29 《"结构件"与"手套"：特斯拉 Optimus 机器人轻量化的"关键一环"—行业 点评报告》-2025.12.22 | 孟鹏飞（分析师） | 欧阳蕤（分析师） | | --- | --- | | mengpengfei@kysec.cn | ouyangrui@kysec.cn | 证书编号：S0790522060001 证书编号：S0790525060002 人形机器人板块呈震荡向上，趋势确立 近期人形机器人板块指数在前一周强劲上涨后呈现震荡向上走势。本周（1 月 5 日-1 月 9 日，全文同）沪深 300 指 ...

Core Viewpoint - Hanwei Technology (300007) has made breakthroughs in the research and development of non-invasive flexible brain-machine interface materials and flexible neural electrode materials, although these technologies are still in the early stages and commercial application remains uncertain [1] Group 1 - The company has focused on flexible micro-nano sensor technology in recent years [1] - Key technological advancements include complex brain information collaborative monitoring and implantable flexible neural electrode materials [1] - The company collaborates with medical institutions and university research teams for R&D [1]

Core Viewpoint - The company has confirmed that its MEMS sensor packaging and testing production line has reached the intended operational status, and the products from this project can be utilized in various applications, including potentially providing "electronic noses" for embodied intelligent robots [1]. Group 1 - The fundraising project for the MEMS sensor packaging and testing line includes various products such as MEMS gas sensors and MEMS pressure sensors [1]. - The products from the MEMS sensor production line are applicable in multiple downstream sectors [1].

Core Viewpoint - The company, Hanwei Technology, does not currently engage in the production of quantum sensors or applications in quantum technology [2] Group 1 - Investors inquired about the company's involvement in quantum sensors on an investor interaction platform [2] - Hanwei Technology confirmed that it does not have products related to quantum technology at this time [2]